Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

George T Grossberg

Showing results (71-80 of 133) with videos related to

Pageof 14
Sort By:
Current Alzheimer Research|December 20, 2014
Evaluating high-dose rivastigmine patch in severe Alzheimer's disease: analyses with concomitant memantine usage as a factorGeorge T Grossberg, Martin R Farlow, Xiangyi Meng, et al.
Expert Opinion on Drug Safety|January 25, 2020
An update on the utility and safety of cholinesterase inhibitors for the treatment of Alzheimer's diseaseAndrea Haake, Kevin Nguyen, Lauren Friedman, et al.
Journal of Geriatric Psychiatry and Neurology|July 5, 2021
Mood Disorders and Anxiety in Parkinson's Disease: Current ConceptsHendrik Lintel, Timothy Corpuz, Saif-Ur-Rahman Paracha, et al.
Journal of Alzheimer'S Disease : JAD|February 12, 2019
Present Algorithms and Future Treatments for Alzheimer's DiseaseGeorge T Grossberg, Gary Tong, Anna D Burke, et al.
Drugs & Aging|November 9, 2017
Recent Progress in the Pharmacotherapy of Alzheimer's DiseaseRita Khoury, Kush Patel, Jake Gold, et al.
Current Alzheimer Research|February 22, 2008
Memantine treatment in patients with mild to moderate Alzheimer's disease already receiving a cholinesterase inhibitor: a randomized, double-blind, placebo-controlled trialAnton P Porsteinsson, George T Grossberg, Jacobo Mintzer, et al.
Expert Opinion on Investigational Drugs|June 1, 2018
The role of 5 HT6-receptor antagonists in Alzheimer's disease: an updateRita Khoury, Noam Grysman, Jake Gold, et al.
Dementia and Geriatric Cognitive Disorders|February 6, 2009
Memantine therapy of behavioral symptoms in community-dwelling patients with moderate to severe Alzheimer's diseaseGeorge T Grossberg, Vojislav Pejović, Michael L Miller, et al.
Annals of Clinical Psychiatry : Official Journal of the American Academy of Clinical Psychiatrists|July 21, 2018
Empathy changes in neurocognitive disorders: A reviewZachary Bartochowski, Shravan Gatla, Rita Khoury, et al.
International Journal of Geriatric Psychiatry|November 10, 2011
Rivastigmine transdermal patch and capsule in Alzheimer's disease: influence of disease stage on response to therapyMartin R Farlow, George T Grossberg, Xiangyi Meng, et al.
Pageof 14

Showing results (71-80 of 133) with videos related to

Sort By:
Pageof 14
Current Alzheimer Research|December 20, 2014
Evaluating high-dose rivastigmine patch in severe Alzheimer's disease: analyses with concomitant memantine usage as a factorGeorge T Grossberg, Martin R Farlow, Xiangyi Meng, et al.
Expert Opinion on Drug Safety|January 25, 2020
An update on the utility and safety of cholinesterase inhibitors for the treatment of Alzheimer's diseaseAndrea Haake, Kevin Nguyen, Lauren Friedman, et al.
Journal of Geriatric Psychiatry and Neurology|July 5, 2021
Mood Disorders and Anxiety in Parkinson's Disease: Current ConceptsHendrik Lintel, Timothy Corpuz, Saif-Ur-Rahman Paracha, et al.
Journal of Alzheimer'S Disease : JAD|February 12, 2019
Present Algorithms and Future Treatments for Alzheimer's DiseaseGeorge T Grossberg, Gary Tong, Anna D Burke, et al.
Drugs & Aging|November 9, 2017
Recent Progress in the Pharmacotherapy of Alzheimer's DiseaseRita Khoury, Kush Patel, Jake Gold, et al.
Current Alzheimer Research|February 22, 2008
Memantine treatment in patients with mild to moderate Alzheimer's disease already receiving a cholinesterase inhibitor: a randomized, double-blind, placebo-controlled trialAnton P Porsteinsson, George T Grossberg, Jacobo Mintzer, et al.
Expert Opinion on Investigational Drugs|June 1, 2018
The role of 5 HT6-receptor antagonists in Alzheimer's disease: an updateRita Khoury, Noam Grysman, Jake Gold, et al.
Dementia and Geriatric Cognitive Disorders|February 6, 2009
Memantine therapy of behavioral symptoms in community-dwelling patients with moderate to severe Alzheimer's diseaseGeorge T Grossberg, Vojislav Pejović, Michael L Miller, et al.
Annals of Clinical Psychiatry : Official Journal of the American Academy of Clinical Psychiatrists|July 21, 2018
Empathy changes in neurocognitive disorders: A reviewZachary Bartochowski, Shravan Gatla, Rita Khoury, et al.
International Journal of Geriatric Psychiatry|November 10, 2011
Rivastigmine transdermal patch and capsule in Alzheimer's disease: influence of disease stage on response to therapyMartin R Farlow, George T Grossberg, Xiangyi Meng, et al.
Pageof 14